EditorialEditorial
The Herpes Zoster Vaccine in Rheumatic Diseases: Duration of Response
ERIN SHIRLEY and ELIZA F. CHAKRAVARTY
The Journal of Rheumatology July 2017, 44 (7) 968-969; DOI: https://doi.org/10.3899/jrheum.170321
ERIN SHIRLEY
Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma,
USA.
BSELIZA F. CHAKRAVARTY
Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma,
USA.
MDRoles: Associate Member
REFERENCES
- 1.↵
- Yamaoka K
- 2.↵
- Oxman MN,
- Levin MJ,
- Johnson GR,
- Schmader KE,
- Straus SE,
- Gelb LD,
- et al.
- 3.↵
- 4.↵
- 5.↵
- Yun H,
- Xie F,
- Baddley JW,
- Winthrop K,
- Saag KG,
- Curtis JR
- 6.↵
- Morrison VA,
- Johnson GR,
- Schmader KE,
- Levin MJ,
- Zhang JH,
- Looney DJ,
- et al.
- 7.↵
- Yun H,
- Yang S,
- Chen L,
- Xie F,
- Winthrop K,
- Baddley JW,
- et al.
In this issue
The Journal of Rheumatology
Vol. 44, Issue 7
1 Jul 2017
The Herpes Zoster Vaccine in Rheumatic Diseases: Duration of Response
ERIN SHIRLEY, ELIZA F. CHAKRAVARTY
The Journal of Rheumatology Jul 2017, 44 (7) 968-969; DOI: 10.3899/jrheum.170321